Ustekinumab for chronic plaque psoriasis.
Bartlett
Brenda L
BL
Center for Clinical Studies and Department of Dermatology, University of Texas Health Science Center, Houston, TX 77030, USA.
Tyring
Stephen K
SK
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use*; D002908:Chronic Disease; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D018664:Interleukin-12 / Q000276:immunology*; D053759:Interleukin-23 / Q000276:immunology*; D007641:Keratolytic Agents / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy* / Q000503:physiopathology
D000911:Antibodies, Monoclonal; D053759:Interleukin-23; D007641:Keratolytic Agents; D018664:Interleukin-12